GeneTex
  • Country / Location Selection

United States (US)

Hypoxia

The 2019 Nobel Prize in Physiology or Medicine was awarded to William G. Kaelin Jr., Sir Peter J. Ratcliffe, and Gregg L. Semenza in recognition of their discovery of cellular mechanisms to sense and adapt to different oxygen concentrations, establishing a basis for how oxygen levels affect physiological function. Their work contributed new understanding of normal processes involving metabolism, embryonic development, and the immune response, among others. In addition, novel perspectives on pathological states including anemia, ischemia, infection, and cancer were derived from their research.

Dr. Semenza identified hypoxia-inducible factor (HIF-1α and ARNT, also known as HIF-1β), the primary transcription factor complex that drives expression of hypoxia-regulated proteins such as vascular endothelial growth factor (VEGF), erythropoietin (EPO), and carbonic anhydrase IX (CAIX). Drs. Kaelin and Ratcliffe described the proteasomal degradation of HIF-1α during normoxia through its interaction with the von Hippel-Lindau tumor suppressor protein (VHL), and how this interaction is enabled by prolyl hydroxylation (Fig. 1).

Hypoxia

Fig. 1. Hypoxia regulation

Under hypoxic conditions (top), HIF-1α remains intact and enters the nucleus to interact with HIF-1β to effect gene expression that promotes hypoxia adaptability. In contrast, with normoxia (bottom), HIF-1α is hydroxylated by prolyl hydroxylases with subsequent binding to VHL, ubiquitination (Ub), and proteasomal degradation.

Genes regulated by HIF-1α (Fig. 2) are important for tumor metabolism, proliferation, survival, angiogenesis, and metastasis. Therefore, inhibition of HIF-1α and its related proteins has become a promising direction for anticancer therapy research.

Hypoxia

Fig. 2. Genes that are regulated by HIF-1α

As oxygen supply in a tumor is frequently suboptimal, cancer cells often increase the expression of HIF-1α to stimulate gene expression that allows them to survive, proliferate, invade surrounding tissue, and metastasize to distant sites. In addition, the hypoxic tumor milieu can make cancer cells less sensitive to chemotherapy and radiotherapy.

Since 2012, GeneTex has been dedicated to the development of antibody reagents that facilitate hypoxia research. These products are rigorously evaluated for specificity and performance through our enhanced validation protocols, and are supported by multiple citations.

View Completed List
Featured Products
Citation Support   KOKD Validation Comparable Abs IP/MS Analysis Orthogonal Validation Protein Overexpression
HIF1 alpha antibody

HIF1 alpha antibody
(GTX127309)

Citation Support KOKD Validation Orthogonal Validation Protein Overexpression
HIF1 beta antibody

HIF1 beta antibody
(GTX128795)

HIF2 alpha antibody

HIF2 alpha antibody
(GTX30114)

Citation Support Orthogonal Validation Protein Overexpression
 
Von Hippel Lindau antibody

Von Hippel Lindau antibody
(GTX101087)

Citation Support Comparable Abs Orthogonal Validation
PHD1 antibody

PHD1 antibody
(GTX123033)

Citation Support
Carbonic Anhydrase IX antibody [GT12]

Carbonic Anhydrase IX antibody [GT12]
(GTX70020)

Citation Support Orthogonal Validation
 
PHD2 antibody

PHD2 antibody
(GTX132293)

Citation Support Orthogonal Validation
Beclin 1 antibody

Beclin 1 antibody
(GTX133555)

Citation Support KOKD Validation Comparable Abs Orthogonal Validation
VEGF antibody

VEGF antibody
(GTX132777)

Citation SupportOrthogonal Validation
 
Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Newsletter
GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]

GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]

GeneTex's RAS (G12D mutant) recombinant antibody is suitable for IHC staining and WB.
Newsletter

A Cancer Immunotherapy Holy Grail?

A Cancer Immunotherapy Holy Grail?
Literature

Pamphlet - Antibodies for Hypoxia Research

Download the latest version of GeneTex's Antibodies for Hypoxia Research pamphlet.
Literature
World Class Validated Antibodies

Brochure - World Class Validated Antibodies

Download the latest version of GeneTex's World Class Validated Antibodies brochure.
Literature
Cancer Signaling

Poster - Cancer Signaling

Download the latest version of GeneTex's cancer signaling poster
Literature

Flyer - RNA-binding Proteins

Download the latest version of GeneTex's RNA-binding proteins flyer.
Literature

Pamphlet - Hot Products

Download the latest version of GeneTex's pamphlet of hot products.
Literature
Antibodies for Cancer Research

Pamphlet - Antibodies for Cancer Research

Download the latest version of GeneTex's pamphlet of antibodies for cancer research
Literature
Cancer Immune Checkpoint

Flyer - Cancer Immune Checkpoints

Download the latest version of GeneTex's cancer immune checkpoint flyer
Literature
Hypoxia Regulation

Poster - Hypoxia Regulation

Download the latest version of GeneTex's hypoxia regulation poster
Literature

Pamphlet - Antibodies for Hypoxia Research

Download the latest version of GeneTex's Antibodies for Hypoxia Research pamphlet.
Literature
World Class Validated Antibodies

Brochure - World Class Validated Antibodies

Download the latest version of GeneTex's World Class Validated Antibodies brochure.
Literature
Cancer Signaling

Poster - Cancer Signaling

Download the latest version of GeneTex's cancer signaling poster
Literature

Flyer - RNA-binding Proteins

Download the latest version of GeneTex's RNA-binding proteins flyer.
Literature

Pamphlet - Hot Products

Download the latest version of GeneTex's pamphlet of hot products.
Literature
Antibodies for Cancer Research

Pamphlet - Antibodies for Cancer Research

Download the latest version of GeneTex's pamphlet of antibodies for cancer research
Literature
Cancer Immune Checkpoint

Flyer - Cancer Immune Checkpoints

Download the latest version of GeneTex's cancer immune checkpoint flyer
Literature
Hypoxia Regulation

Poster - Hypoxia Regulation

Download the latest version of GeneTex's hypoxia regulation poster